Mark Bock,Ming-Hong Hao,Manav Korpal,Vijay Kumar Nyavanandi,Xiaoling Puyang,Susanta Samajdar,Peter Gerard Smith,John Wang,Guo Zhu Zheng,Ping Zhu,Lorna Helen Mitchell,Nicholas Larsen,Nathalie Rioux,Sud
申请号：
US16349479
公开号：
US20200255415A1
申请日:
2017.11.22
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.
